YC S24
Kopra Bio
Genetically engineered viruses that teach your immune system to kill…
About
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.
Founder
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Kopra Bio.
See family office activityIndustry & Focus
HealthcareTherapeuticsGene TherapySynthetic BiologyBiotechOncology